STOCK TITAN

Agios Pharmaceuticals: Lynx1 reports 0.8% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Agios Pharmaceuticals, Inc. (AGIO) is the issuer in an amended Schedule 13G reporting that investment manager Lynx1 Capital Management LP and Weston Nichols, the sole member of its general partner, each beneficially own 472,606 common shares, or 0.8% of the class. The shares are held directly by the Lynx1 Fund, and both reporting persons report shared voting and dispositive power over them. Agios had 59,701,882 common shares outstanding as of July 24, 2026, the basis for the ownership percentage.

Beneficial ownership reported by each reporting person 472,606 shares The shares are directly held by the Lynx1 Fund.
Shared voting and dispositive power 472,606 shares Both reporting persons report shared voting and dispositive power over the shares.
Ownership percentage 0.8% Percentage of Agios common stock, calculated using shares outstanding as of July 24, 2026.
Common shares outstanding 59,701,882 shares As of July 24, 2026.
Sole voting and dispositive power 0 shares Each reporting person reports zero sole voting power and zero sole dispositive power.
beneficial ownership technical
"Amount beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Power technical
"Shared Voting Power 472,606.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power technical
"Shared Dispositive Power 472,606.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AGIO shares do Lynx1 Capital Management and Weston Nichols report owning?

Lynx1 Capital Management LP and Weston Nichols each report beneficial ownership of 472,606 Agios common shares, representing 0.8% of the class. The shares are held directly by the Lynx1 Fund.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





00847X104

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Lynx1 Capital Management LP
Signature:/s/ Weston Nichols
Name/Title:Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Date:11/16/2026
Weston Nichols
Signature:/s/ Weston Nichols
Name/Title:Weston Nichols, Individually
Date:11/16/2026

Keep reading